2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Sales - EUR | 56.450 | 46.457 | 42.292 | 41.028 | 34.041 | 38.356 | 41.847 | 76.768 | 71.470 | 72.913 |
Total Income - EUR | 56.825 | 46.460 | 42.307 | 41.087 | 34.264 | 44.274 | 41.875 | 76.802 | 124.832 | 72.938 |
Total Expenses - EUR | 39.200 | 30.701 | 29.104 | 35.347 | 36.614 | 47.447 | 39.351 | 46.717 | 120.576 | 63.651 |
Gross Profit/Loss - EUR | 17.625 | 15.758 | 13.204 | 5.740 | -2.350 | -3.173 | 2.524 | 30.085 | 4.256 | 9.288 |
Net Profit/Loss - EUR | 15.920 | 14.364 | 12.781 | 5.329 | -2.693 | -3.615 | 2.135 | 29.371 | 3.007 | 8.558 |
Employees | 3 | 3 | 2 | 3 | 2 | 4 | 3 | 3 | 3 | 3 |
Check the financial reports for the company - Emifarm Vet S.r.l.
2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Fixed Assets | 96.742 | 116.491 | 115.872 | 108.172 | 106.121 | 95.212 | 100.751 | 104.646 | 63.109 | 53.795 |
Current Assets | 14.529 | 9.993 | 8.248 | 7.415 | 6.044 | 7.468 | 10.236 | 46.612 | 23.031 | 29.907 |
Inventories | 4.234 | 6.687 | 4.968 | 4.185 | 4.162 | 2.029 | 5.188 | 8.208 | 9.932 | 9.054 |
Receivables | 1.069 | 605 | 135 | 7 | 59 | 0 | 0 | 34.312 | 4.953 | 11.810 |
Cash | 9.225 | 2.701 | 3.145 | 3.223 | 1.824 | 5.439 | 5.048 | 4.092 | 8.146 | 9.042 |
Shareholders Funds | 82.947 | 98.004 | 109.785 | 111.067 | 106.336 | 100.640 | 100.867 | 127.932 | 68.430 | 71.042 |
Social Capital | 112 | 112 | 111 | 109 | 107 | 105 | 103 | 101 | 101 | 101 |
Debts | 28.920 | 28.817 | 14.269 | 4.683 | 5.979 | 2.116 | 10.120 | 23.327 | 30.848 | 38.629 |
Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Exchange rate - RON | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 | 4.4821 |
Main CAEN | "7500 - 7500" | |||||||||
CAEN Financial Year |
7500
|
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Comments - Emifarm Vet S.r.l.